外科重症监护中的肠内与肠外营养:血浆代谢组学显示对氮、脂肪酸、核糖核苷酸和氧化代谢的不同影响
该研究于2015年在城市一级创伤中心前瞻性纳入30例重症患者,其中10例接受肠内营养(EN)、10例接受肠外营养(PN),在营养启动前1-12小时及启动后3天、7天采集血浆,用液相色谱/质谱代谢组学分析。EN组氨基酸和尿素循环代谢物(瓜氨酸 p=0.04、鸟氨酸 p=0.05)及核糖核酸代谢物(尿苷 p=0.04、半胱氨酸 p=0.05、氧嘌呤醇 p=0.04)升高,氧化应激随时间下降(甜菜碱升高 p=0.05、4-吡哆酸降低 p=0.04)。PN组氨基酸浓度升高(牛磺酸 p=0.04、苯丙氨酸 p=0.05),omega-6和omega-3脂肪酸浓度随时间下降(p=0.05和0.03)。作者认为肠外氨基酸利用效率低于肠内给予,所报告的生物标志物可能有助于指导重症患者的营养治疗。
要点
- 在重症患者中,肠内营养组瓜氨酸(p=0.04)和鸟氨酸(p=0.05)升高,提示尿素循环上调。
- 肠内营养组尿苷(p=0.04)、半胱氨酸(p=0.05)、氧嘌呤醇(p=0.04)升高,提示核糖核酸合成增加。
- 肠内营养组甜菜碱升高(p=0.05)、4-吡哆酸降低(p=0.04),提示氧化应激随时间下降。
- 肠外营养组牛磺酸(p=0.04)和苯丙氨酸(p=0.05)升高,但未影响蛋白质代谢或抗氧化剂补充。
- 肠外营养组omega-6和omega-3脂肪酸浓度随时间下降(p=0.05和0.03)。
适用人群与场景
- 2015年7个月内在城市一级创伤中心前瞻性纳入的30例重症患者,其中10例接受肠内营养、10例接受肠外营养。
- 纳入标准为住院期间开始肠内营养或肠外营养前。
研究设计与关键结果
- 研究类型为前瞻性研究,纳入30例重症患者,其中10例接受肠内营养、10例接受肠外营养。
- 肠内营养组氨基酸和尿素循环代谢物升高:瓜氨酸 p=0.04,鸟氨酸 p=0.05。
- 肠内营养组核糖核酸代谢物升高:尿苷 p=0.04,半胱氨酸 p=0.05,氧嘌呤醇 p=0.04。
- 肠内营养组氧化应激随时间下降:甜菜碱升高 p=0.05,4-吡哆酸降低 p=0.04。
- 肠外营养组氨基酸浓度随时间升高:牛磺酸 p=0.04,苯丙氨酸 p=0.05。
- 肠外营养组omega-6和omega-3脂肪酸浓度随时间下降,p=0.05和0.03。
证据类型、等级与局限
- 证据类型:前瞻性研究;证据等级:治疗性研究III级,预后性研究II级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,肠外氨基酸利用效率低于肠内给予的氨基酸。
- 作者认为,本研究报告的生物标志物可能有助于指导重症患者的营养治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Artificial nutrition support is central to the care of critically ill patients and is primarily provided enterally (EN). There are circumstances when parenteral nutrition (PN) is considered necessary. We are uncertain how each of these approaches confer clinical benefits beyond simply providing calories. We sought to better understand how each of these techniques influence metabolism in critically ill patients using a broad-based metabolomics approach. Metabolic responses to EN and PN may differ in ways that could help us understand how to optimize use of these therapies.
METHODS: We prospectively enrolled subjects over 7 months in 2015 at an urban, Level I trauma center. Subjects were included before starting either EN or PN during their inpatient admission. Plasma samples were obtained between 1 and 12 hours before initiation of artificial nutrition, and 3 and 7 days later. All samples were analyzed with liquid chromatography/mass spectrometry-based metabolomics. Differences in metabolite concentrations were assessed via principal component analyses and multiple linear regression.
RESULTS: We enrolled 30 subjects. Among the critically ill subjects, 10 received EN and 10 received PN. In subjects receiving EN, amino acid and urea cycle metabolites (citrulline, p = 0.04; ornithine, p = 0.05) increased, as did ribonucleic acid metabolites (uridine, p = 0.04; cysteine, 0 = 0.05; oxypurinol, p = 0.04). Oxidative stress decreased over time (increased betaine, p = 0.05; decreased 4-pyridoxic acid, p = 0.04). In subjects receiving PN, amino acid concentrations increased over time (taurine, p = 0.04; phenylalanine, p = 0.05); omega 6 and omega 3 fatty acid concentrations decreased over time (p = 0.05 and 0.03, respectively).
CONCLUSION: EN was associated with amino acid repletion, urea cycle upregulation, restoration of antioxidants, and increasing ribonucleic acid synthesis. Parenteral nutrition was associated with increased amino acid concentrations, but did not influence protein metabolism or antioxidant repletion. This suggests that parenteral amino acids are used less effectively than those given enterally. The biomarkers reported in this study may be useful in guiding nutrition therapy for critically ill patients.
LEVEL OF EVIDENCE: Therapeutic study, level III; prognostic study, level II.
参考来源
- Parent BA, Seaton M, Djukovic D, et al. Parenteral and enteral nutrition in surgical critical care: Plasma metabolomics demonstrates divergent effects on nitrogen, fatty-acid, ribonucleotide, and oxidative metabolism. J Trauma Acute Care Surg. 2017. PMID: 28129265. doi:10.1097/TA.0000000000001381
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。